Derivation, Evaluation, and Validation of Illustrations of Key Counselling Points for a Pediatric Eczema Action Plan

Further Publications Immunology

Developing and evaluating a pediatric asthma severity computable phenotype derived from electronic health records

J Allergy Clin Immunol

Peer K, Adams WG, Legler A, Sandel M, Levy JI, Boynton-Jarrett R, Kim C, Leibler JH, Fabian MP

doi: 10.1016/j.jaci.2020.11.045

Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy

J Pediatr Hematol Oncol.

Palen K, Thakar M, Johnson BD, Gershan JA

doi: 10.1097/

Rheumatoid Arthritis

A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis

Clin Rheumatol.

Sun X, Deng X, Geng Y, Ji L, Xie W, Zhang X, Zhang Z

doi: 10.1007/

Systemic Lupus Erythematosus

Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity

Ann Rheum Dis.

Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, Da Silva JAP, Doria A, Inês LS

doi: 10.1136/annrheumdis-2018-214502.

Immunotherapy

Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome

Pediatr Neurol.

Pranzatelli MR, Tate ED

doi: 10.1016/

Atopic Dermatitis

Recurrent Eczema Herpeticum - A Retrospective European Multicenter Study Evaluating the Clinical Characteristics of Eczema Herpeticum Cases in Atopic Dermatitis Patients

J Eur Acad Dermatol Venereol.

Seegräber M, Worm M, Werfel T, Svensson A, Novak N, Simon D, Darsow U, Augustin M, Wollenberg A

doi: 10.1111/jdv.16090.

Atopic Dermatitis

Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)

Br J Dermatol.

Howells L, Chalmers JR, Gran S, Ahmed A, Apfelbacher C, Burton T, Howie L, Lawton S, Ridd M, Rogers NK, Sears AV, Spuls P, von Kobyletzki L, Thomas KS

doi: 10.1111/bjd.18780.

Further Publications Immunology

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients

Pediatr Allergy Immunol

Dekkers C, Alizadeh Aghdam M, Graaf M, Knulst AC, Meijer Y, van den Reek JMPA, Stadermann MB, Röckmann H

doi: 10.1111/pai.13426

Atopic Dermatitis

Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial

JAMA Pediatr.

Chan S, Cornelius V, Cro S, Harper JI, Lack G

doi: 10.1001/jamapediatrics.2019.4476.

Related content

Developing and evaluating a pediatric asthma severity computable phenotype derived from electronic health records

Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy

A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis

Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity

Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome

Recurrent Eczema Herpeticum - A Retrospective European Multicenter Study Evaluating the Clinical Characteristics of Eczema Herpeticum Cases in Atopic Dermatitis Patients

Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients

Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial